InvestorsHub Logo

Enterprising Investor

12/17/18 7:45 AM

#84 RE: Enterprising Investor #83

It is highly unlikely that sales of AUGMENT® Bone Graft will reach $70 million for the 12-month period ending 3/01/19 and generate the additional $1.50 payment for CVR holders.

Trust me, I hope the statement above turns out wrong. My brokerage accounts could use the boost. I own 125,000 CVRs.

The run rate increased only $410 thousand between the October and November reporting periods.

Enterprising Investor

01/14/19 12:58 PM

#85 RE: Enterprising Investor #83

CVR Product Sales Statement (12/30/18)

December 30, 2018

AUGMATRIX
$27,081

AUGMENT
$41,514,550

Total Product Global Sales
$41,541,631

Canadian Dollar Exchange Rate
0.772

Australian Dollar Exchange Rate
0.747

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9Mzg2NjE3fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636380628739202372